Who are FS VH S/D 4 s-apr's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/fs-vh-s-d-4-s-apr.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

FS VH S/D 4 s-apr — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FS VH S/D 4 s-apr (FS VH S/D 4 s-apr) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Fresh frozen plasma (pathogen-reduced). Area: Hematology / Transfusion Medicine.

phase 3 Fresh frozen plasma (pathogen-reduced) Hematology / Transfusion Medicine Biologic Live · refreshed every 30 min

Target snapshot

FS VH S/D 4 s-apr (FS VH S/D 4 s-apr) — Baxter Healthcare Corporation. FS VH S/D 4 s-apr is a solvent/detergent-treated fresh frozen plasma product designed to provide clotting factors and other plasma proteins while reducing the risk of viral transmission.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
FS VH S/D 4 s-apr TARGET	FS VH S/D 4 s-apr	Baxter Healthcare Corporation	phase 3	Fresh frozen plasma (pathogen-reduced)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Fresh frozen plasma (pathogen-reduced) class)

Baxter Healthcare Corporation · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). FS VH S/D 4 s-apr — Competitive Intelligence Brief. https://druglandscape.com/ci/fs-vh-s-d-4-s-apr. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab